1,050
Participants
Start Date
September 30, 2014
Primary Completion Date
April 30, 2018
Study Completion Date
April 30, 2018
Xpert MTB/RIF®, Determine TB LAM, Chest X-ray
"The following point-of-care TB tests will be systematically performed:~Xpert MTB/RIF® on sputum (in all patients able to provide sputum; no sputum induction will be requested in others), Urine LAM (all patients). Depending on clinical presentation, Xpert MTB/RIF® will also be performed on any relevant extra-pulmonary specimen.~TB treatment will depend on the result of the tests:~Criteria met for confirmed or probable TB : TB treatment will be initiated immediately (Visit 1) followed by ART initiation 2 weeks later (Visit 2); No evidence of confirmed or probable TB: ART will be started immediately (Visit 1)."
ART (Atripla, Truvada, Efavirenz, Combivir)
"* ART (TDF-3TC/FTC or AZT-3TC + efavirenz) will be started immediately after randomization in patients not put on TB treatment, and 2 weeks after initiation of TB treatment in others.~* ART will be initiated 2 weeks after the onset of TB treatment (V2) for Arm 2"
Rifampin, isoniazid, pyrazinamide, ethambutol
Arm 1: Only patients who meet standardized criteria for TB at inclusion or during follow-up will receive a standard TB treatment (2ERHZ/4RH); Arm 2: • All patients will start a 6-month standard TB treatment (2ERHZ/4RH) at randomization
CePReF Centre de Prise en charge de Recherche et de Formation, Abidjan
ISS ImmunoSuppression Service, Mbarara
Sihanouk Hospital Center of Hope, Phnom Penh
Pham Ngoc Thach Hospital, Ho Chi Minh City
ANRS, Emerging Infectious Diseases
OTHER_GOV